Skip to navigation menu Skip to content
Current Research Studies

ALTE2321, Walking Juntos: Developing and Testing a Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors A COG Groupwide Phase 2b Study

ALTE2321_Walking Juntos

  • Condition(s): Kaposi's Sarcoma, Other Digestive Organ, Ill-Defined Sites, Soft Tissue, Larynx, Non-malignant Disease, Other Respiratory and Intrathoracic Organs, Lip, Oral Cavity and Pharynx, Liver, Pancreas, Other Endocrine System, Other Male Genital, Anus, Lymphoid Leukemia, Hodgkin's Lymphoma, Myeloid and Monocytic Leukemia, Prostate, Melanoma, Skin, Bones and Joints, Lung, Ovary, Mycosis Fungoides, Rectum, Multiple Myeloma, Stomach, Cervix, Other Skin, Kidney, Other Hematopoietic, Leukemia, other, Esophagus, Corpus Uteri, Brain and Nervous System, Other Female Genital, Unknown Sites, Non-Hodgkin's Lymphoma, Other Urinary, Small Intestine, Eye and Orbit, Thyroid, Colon, Urinary Bladder, Breast
  • Phase: II
  • Clinicaltrials.gov ID: NCT06410209

What is the goal of the study?

The purpose of this study is to test the efficacy of a physical activity program to meet the unique needs of Hispanic or Latino/a adolescents and young adults after cancer treatment. For stage 1, ALTE2321 will enroll self-identified Hispanic or Latino/a cancer survivors and the central coordinator center will proceed with remaining steps where participants complete an initial survey and 3 Rounds of reviewing the program materials and qualitative interviews (phone conversations) so that the study team can learn what participants think about the physical activity programs proposed. Stage 2 will only begin after stage 1 is completed and will be fully detailed based on feedback provided by Stage 1 participants. Stage 2 will involve participants being randomized to the Intervention Group or Control Group. All Stage 2 participants will receive a PA tracker (such as a Fitbit) and will complete Baseline and Final evaluations (Surveys, Accelerometers, Anthropometrics, 2-Minute Step Test). The evaluations can be completed in-person (in clinic) or remotely (by phone/video conference). In addition to the PA tracker, the Intervention Group will be offered a culturally-tailored multi-component PA program. Finally, a subset of participants in the Intervention Group will be invited to take part in one of two qualitative interviews. Stage 1 has been finished and SCH will only participate in stage 2.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: